Work

Antibody-interferon-alpha fusion protein (IGN002) for the treatment of b-cell non-Hodgkin lymphomas: A phase 1, first-in-human, dose-escalation trial.

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.15_suppl.tps3109

Authors: Patricia Ann Young, Nam H. Dang, Loretta J. Nastoupil, Dena Minning, Michael J. Gresser, John Timmerman

Institutions: University of California, Los Angeles, University of Florida, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2890505756

Cites:

Cited by: 6

Related to: 10